UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

CYP2D6 is a major determinant of metoprolol disposition and effects in hospitalized Russian patients treated for acute myocardial infarction

European journal of clinical pharmacology, 2008-12, Vol.64 (12), p.1163-1173

2008

Volltextzugriff (PDF)

The Radiation Injury Severity Classification system: an early injury assessment tool for the frontline health-care provider

British journal of radiology, 2008-03, Vol.81 (963), p.232

2008

Volltextzugriff (PDF)

A 52-week open-label study of the safety and tolerability of paliperidone palmitate in patients with schizophrenia

Journal of psychopharmacology (Oxford), 2011-05, Vol.25 (5), p.685-697

2011

Volltextzugriff (PDF)

The Stop Arthritis Very Early (SAVE) trial, an international multicentre, randomised, double-blind, placebo-controlled trial on glucocorticoids in very early arthritis

Annals of the rheumatic diseases, 2010-03, Vol.69 (3), p.495-502

2010

Volltextzugriff (PDF)

Randomised clinical trial: a comparative dose‐finding study of three arms of dual release mesalazine for maintaining remission in ulcerative colitis

Alimentary pharmacology & therapeutics, 2011-02, Vol.33 (3), p.313-322

2011

Volltextzugriff (PDF)

The role of personal values and basic traits in perceptions of the consequences of immigration: A three-nation study

The British journal of psychology, 2012-08, Vol.103 (3), p.359-377

2012

Volltextzugriff (PDF)

Paliperidone palmitate maintenance treatment in delaying the time-to-relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled study

Schizophrenia research, 2010-02, Vol.116 (2), p.107-117

2010

Volltextzugriff (PDF)

Evidence for Clinical Safety, Efficacy, and Parent and Physician Perceptions of Levocetirizine for the Treatment of Children with Allergic Disease

International archives of allergy and immunology, 2011-07, Vol.155 (4), p.367-378

2011

Volltextzugriff (PDF)

Effects of Hepatic Impairment on the Pharmacokinetics of Everolimus: A Single-Dose, Open-Label, Parallel-Group Study

Clinical therapeutics, 2013-03, Vol.35 (3), p.215-225

2013

Volltextzugriff (PDF)

A randomised, double-blind, placebo-controlled phase 2 study of trebananib (AMG 386) in combination with FOLFIRI in patients with previously treated metastatic colorectal carcinoma

British journal of cancer, 2013-02, Vol.108 (3), p.503-511

2013

Volltextzugriff (PDF)

Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome

Alimentary pharmacology & therapeutics, 2011-08, Vol.34 (4), p.432-442

2011

Volltextzugriff (PDF)

Nonparametric population modeling of valproate pharmacokinetics in epileptic patients using routine serum monitoring data: implications for dosage

Journal of clinical pharmacy and therapeutics, 2004-04, Vol.29 (2), p.105-120

2004

Volltextzugriff (PDF)

A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer

Breast cancer research and treatment, 2013, Vol.137 (2), p.471-482

2013

Volltextzugriff (PDF)

Randomized, double‐blind placebo‐ and tolterodine‐controlled trial of the once‐daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder

BJU international, 2004-02, Vol.93 (3), p.303-310

2004

Volltextzugriff (PDF)

Randomized trial of peginterferon alfa‐2b and ribavirin for 48 or 72 weeks in patients with hepatitis C virus genotype 1 and slow virologic response

Hepatology (Baltimore, Md.), 2010-10, Vol.52 (4), p.1201-1207

2010

Volltextzugriff (PDF)

Three‐Year Efficacy and Safety Results from a Study of Everolimus Versus Mycophenolate Mofetil in de novo Renal Transplant Patients

American journal of transplantation, 2005-10, Vol.5 (10), p.2521-2530

2005

Volltextzugriff (PDF)

Paliperidone extended-release in patients with non-acute schizophrenia previously unsuccessfully treated with other oral antipsychotics

Expert opinion on pharmacotherapy, 2014-04, Vol.15 (5), p.593-603

2014

Volltextzugriff (PDF)

A Multicenter, Randomized, Double-Blind Trial of Everolimus Versus Azathioprine and Placebo to Maintain Steroid-Induced Remission in Patients With Moderate-to-Severe Active Crohn's Disease

The American journal of gastroenterology, 2008-09, Vol.103 (9), p.2284-2292

2008

Volltextzugriff (PDF)

Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma

Lung cancer (Amsterdam, Netherlands), 2014-09, Vol.85 (3), p.429-434

2014

Volltextzugriff (PDF)

Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia

International journal of gynecology and obstetrics, 2008-04, Vol.101 (1), p.67-73

2008

Volltextzugriff (PDF)

A Screening Study of Thyroid Cancer and Other Thyroid Diseases among Individuals Exposed in Utero to Iodine-131 from Chernobyl Fallout

The journal of clinical endocrinology and metabolism, 2009-03, Vol.94 (3), p.899-906

2009

Volltextzugriff (PDF)

A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapy

Breast cancer research and treatment, 2008-07, Vol.110 (2), p.327-335

2008

Volltextzugriff (PDF)

Oral ibandronate is as active as intravenous zoledronic acid for reducing bone turnover markers in women with breast cancer and bone metastases

Annals of oncology, 2007-07, Vol.18 (7), p.1165-1171

2007

Volltextzugriff (PDF)

Central and Eastern European Experience with Sunitinib in Metastatic Renal Cell Carcinoma: A Sub-analysis of the Global Expanded-Access Trial

Pathology oncology research, 2015-07, Vol.21 (3), p.775-782

2015

Volltextzugriff (PDF)

When glycaemic targets can no longer be achieved with basal insulin in type 2 diabetes, can simple intensification with a modern premixed insulin help? Results from a subanalysis of the PRESENT study

International journal of clinical practice (Esher), 2008-07, Vol.62 (7), p.1013-1018

2008

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Aktive Filter

SpracheKoreanisch

SpracheEnglisch

SpracheRussisch

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(29)

Sprache

Japanisch
(3)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(29)
Female
(28)
Life Sciences & Biomedicine
(26)
Science & Technology
(26)
Male
(24)
Middle Aged
(24)
Aged
(18)
Treatment Outcome
(13)
Adolescent
(10)
Pharmacology & Pharmacy
(9)
Double-Blind Method
(8)
Time Factors
(7)
Young Adult
(7)
Administration, Oral
(6)
Aged, 80 And Over
(6)
Oncology
(6)
Schizophrenia
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)
Dose-Response Relationship, Drug
(4)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

CYP2D6 is a major determinant of metoprolol disposition and effects in hospitalized Russian patients treated for acute myocardial infarction

The Radiation Injury Severity Classification system: an early injury assessment tool for the frontline health-care provider

A 52-week open-label study of the safety and tolerability of paliperidone palmitate in patients with schizophrenia

The Stop Arthritis Very Early (SAVE) trial, an international multicentre, randomised, double-blind, placebo-controlled trial on glucocorticoids in very early arthritis

Randomised clinical trial: a comparative dose‐finding study of three arms of dual release mesalazine for maintaining remission in ulcerative colitis

The role of personal values and basic traits in perceptions of the consequences of immigration: A three-nation study

Paliperidone palmitate maintenance treatment in delaying the time-to-relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled study

Evidence for Clinical Safety, Efficacy, and Parent and Physician Perceptions of Levocetirizine for the Treatment of Children with Allergic Disease

Effects of Hepatic Impairment on the Pharmacokinetics of Everolimus: A Single-Dose, Open-Label, Parallel-Group Study

A randomised, double-blind, placebo-controlled phase 2 study of trebananib (AMG 386) in combination with FOLFIRI in patients with previously treated metastatic colorectal carcinoma

Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome

Nonparametric population modeling of valproate pharmacokinetics in epileptic patients using routine serum monitoring data: implications for dosage

A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer

Randomized, double‐blind placebo‐ and tolterodine‐controlled trial of the once‐daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder

Randomized trial of peginterferon alfa‐2b and ribavirin for 48 or 72 weeks in patients with hepatitis C virus genotype 1 and slow virologic response

Three‐Year Efficacy and Safety Results from a Study of Everolimus Versus Mycophenolate Mofetil in de novo Renal Transplant Patients

Paliperidone extended-release in patients with non-acute schizophrenia previously unsuccessfully treated with other oral antipsychotics

A Multicenter, Randomized, Double-Blind Trial of Everolimus Versus Azathioprine and Placebo to Maintain Steroid-Induced Remission in Patients With Moderate-to-Severe Active Crohn's Disease

Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma

Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia

A Screening Study of Thyroid Cancer and Other Thyroid Diseases among Individuals Exposed in Utero to Iodine-131 from Chernobyl Fallout

A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapy

Oral ibandronate is as active as intravenous zoledronic acid for reducing bone turnover markers in women with breast cancer and bone metastases

Central and Eastern European Experience with Sunitinib in Metastatic Renal Cell Carcinoma: A Sub-analysis of the Global Expanded-Access Trial

When glycaemic targets can no longer be achieved with basal insulin in type 2 diabetes, can simple intensification with a modern premixed insulin help? Results from a subanalysis of the PRESENT study

Aktive Filter

Suchergebnisse filtern